Paul McBarron

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Berkeley Heights, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul McBarron
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paul McBarron

Form 4 holding E. VP, Fin, CFO, COO and Secretary, Director

Cyclacel Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
33,378
Estimated value
$110,648
Report date
21 Dec 2023
Price
$3.32
Ownership
Direct
Form 4 holding E. VP, Fin, CFO, COO and Secretary, Director

Cyclacel Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
70,200
Estimated value
Report date
30 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding E. VP, Fin, CFO, COO and Secretary, Director

Cyclacel Pharmaceuticals, Inc.

Security class
Warrants (right to buy)
Shares / value
1,886
Estimated value
Report date
21 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paul McBarron

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .